Effectiveness of Dimethyl Fumarate in Real-World Clinical Practice and Strategy to Minimize Adverse Effects and Use of Healthcare Resources

BACKGROUND: Dimethyl fumarate (DMF) has shown efficacy in reducing relapse rates in patients with multiple sclerosis (MS). However, associated adverse effects (AE) such as gastrointestinal (GI) AE, flushing and lymphopenia are the main cause of treatment discontinuation. The aim of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Regal, Ana, Ramos-Rúa, Laura, Anibarro-García, Luis, Lopez Real, Ana María, Amigo-Jorrín, María del Campo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853639/
https://www.ncbi.nlm.nih.gov/pubmed/33542621
http://dx.doi.org/10.2147/PPA.S284425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853639/
https://www.ncbi.nlm.nih.gov/pubmed/33542621
http://dx.doi.org/10.2147/PPA.S284425

Ejemplares similares